Avient (AVNT) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
13 May, 2026Financial performance and outlook
2025 sales reached $3.3B with adjusted EBITDA of $545M and adjusted EPS of $2.82, reflecting a 16.7% EBITDA margin and 15 years of consecutive dividend growth.
Q1 2026 sales were $847M, with adjusted EBITDA of $150M and margin expansion to 17.7%; adjusted EPS of $0.83 exceeded guidance.
2026 full-year guidance projects adjusted EBITDA of $555M–$585M and adjusted EPS of $2.93–$3.17, with 2–7% and 4–12% growth, respectively.
Margin expansion is targeted through productivity, mix improvement, and operating leverage, aiming for 20%+ adjusted EBITDA margins long-term.
Net leverage improved to 2.6x in 2024 and is targeted below 2.5x, with disciplined capital allocation across capex, dividends, debt paydown, share repurchases, and M&A.
Strategic direction and growth drivers
Focus on intersecting high-growth markets and secular trends with technology platforms to drive above-market growth.
Growth vectors include composites for construction, electrification, defense, healthcare, and sustainability solutions.
Core business is expected to grow above GDP, while new platforms target 10%+ CAGR.
Productivity, innovation, and portfolio prioritization are central to the strategy, supported by a culture of safety and sustainability.
Capital allocation supports organic growth, with opportunistic M&A and share buybacks as part of the long-term plan.
Business segments and market exposure
Color, Additives & Inks (CAI) accounted for 62% of 2025 sales, with strong presence in packaging, consumer, and industrial markets.
Specialty Engineered Materials (SEM) made up 38% of 2025 sales, with significant exposure to healthcare, defense, and construction.
Regional sales in 2025 were led by US & Canada (40%), EMEA (36%), Asia (18%), and Latin America (6%).
End markets include packaging (23%), consumer (18%), industrial (14%), transportation (11%), building & construction (10%), healthcare (9%), defense (8%), energy (4%), and telecom (3%).
Raw material basket is 35% hydrocarbon-based, with key inputs including polypropylene, polyethylene, pigments, and performance additives.
Latest events from Avient
- 2026 guidance projects higher margins and EPS, driven by innovation and strong execution.AVNT
Investor presentation14 May 2026 - All voting items passed as 2025 financial targets were met and strategic growth plans outlined.AVNT
AGM 202614 May 2026 - Q1 2026 adjusted EPS rose 9% to $0.83, with sales up and margins expanding.AVNT
Q1 20267 May 2026 - 2025 delivered margin and EPS growth; 2026 guidance targets further gains and investment.AVNT
Q4 202512 Apr 2026 - Annual meeting to vote on directors, executive pay, and auditor ratification, all board-backed.AVNT
Proxy filing27 Mar 2026 - 2026 proxy details innovation-driven strategy, board refresh, and performance-based executive pay.AVNT
Proxy filing27 Mar 2026 - Q2 2024 delivered 21% EPS growth, margin gains, and higher full-year guidance.AVNT
Q2 20242 Feb 2026 - Q3 sales up 8%, adjusted EPS up 14%, and full-year guidance raised amid broad-based growth.AVNT
Q3 202417 Jan 2026 - Targets 20%+ EBITDA margin and double-digit EPS growth through organic expansion in high-growth markets.AVNT
Investor Day 202411 Jan 2026